MedPath

Impact of Coenzyme Q10 and Selenium on Seminal Fluid and Semen Antioxidant Status

Not Applicable
Completed
Conditions
Male Infertility
Interventions
Dietary Supplement: Selenium
Dietary Supplement: Coenzyme Q10
Registration Number
NCT03834831
Lead Sponsor
University of Sumer
Brief Summary

The study was conducted to assess the impact of coenzyme Q10 and selenium on seminal fluid parameters and antioxidant status in infertile men.

Detailed Description

The aim of this study was to assess the impact of coenzyme Q10 and selenium on seminal fluid parameters and antioxidant status in infertile men with idiopathic oligoasthenoteratospermia.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
70
Inclusion Criteria
  • History of infertility of at least 12 months despite regular unprotected intercourse.
  • Oligoasthenoteratospermia was diagnosed by semen analysis showing abnormal sperm concentration (<15 million/ml), progressive motility (<32%), total motility (<40%) and morphology (<30% WHO criteria) as defined by WHO manual for semen analysis 2010
Exclusion Criteria
  • Azoospermia,
  • Varicocele,
  • Genital tract infection,
  • Cryptorchidism,
  • Testicular trauma or scrotal surgery,
  • Endocrine disorder,
  • Systemic illness,
  • Smoking
  • The presence of female factor

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SeleniumSeleniumSelenium mcg/day for 3 months
Coenzyme Q10Coenzyme Q10Coenzyme Q10 200mg/day for 3 months
Primary Outcome Measures
NameTimeMethod
Sperm concentration in semen (WHO 2010 guidelines)3 months

Sperm concentration in million/ml

Semen volume (WHO 2010 guidelines)3 months

Semen volume in ml

Sperm morphology in semen (WHO 2010 guidelines)3 months

Normal sperm morphology (%)

Seminal plasma TAC (Colorimetric assays)3 months

Seminal plasma total antioxidant capacity in mmol/ml

Seminal plasma CAT (Colorimetric assays)3 months

Seminal plasma catalase in U/ml

Sperm motility in semen (WHO 2010 guidelines)3 months

Sperm motility (%)

Seminal plasma SOD (Colorimetric assays)3 months

Superoxide dismutase in U/ml

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fertility Unit, Babyl

🇮🇶

Hilla, Iraq

© Copyright 2025. All Rights Reserved by MedPath